Now is the time to embrace change and ramp up clinical programs as states expand pharmacy practice and health plans contract for value-based services, says Duane Jones, Arkansas CPESN Luminary. Jones, who also serves on CPESN USA's Executive Committee, gives Arkansas' test to treat law as an example of opportunity amid rapid market change. Credentialed pharmacists are paid on the medical side for office visits to treat strep, flu, and Covid-19. "Call your local network. Call your Managing Network Facilitator. Get involved."

Hawaii Medical Services Association (HMSA) recently renewed a two-year contract with CPESN Hawaii to continue a gap closure program focused on increasing adherence for Medicare patients. Kerri Okamura, Program Support Lead for the Pacific Region, says the renewal adds an annual administrative payment to the fee-for-services program.

As CPESN Mississippi pharmacies reached out to their UnitedHealthcare patients to collect blood pressure and A1c readings, they were able to meet additional needs and help patients overcome barriers to care. Amy Catherine Love Baggett, owner of Love's Pharmacy in Diamondhead and the network's Managing Network Facilitator shares how the payer program to close HEDIS® led to care coordination successes.

Alison Haas, CPESN USA Director of Value-Based Contracting, does the 2023 Success Countdown with lots of wins as improved patient outcomes, achieved payer goals, and increased revenue for CPESN community pharmacies.

Kevin Day, owner of Day's Pharmacies and CPESN Ohio Managing Network Facilitator, describes the statewide Medicaid program exclusive to CPESN Ohio network pharmacists that allows billing for provider-status initiatives without a collaboration agreement. The program for Humana's Medicaid enrollees has a January 1, 2024 start date.

Tough times, turbulent times, and unimaginable industry change - familiar words for community pharmacy. How to make it through the coming months, positioned for opportunity? Randy McDonough, CPESN Iowa and USA Luminary, and a member of the CPESN USA Board of Managers shares his insights.

John Croce, CPESN USA Program Lead for Drug Clinical Trials, describes a growing non-dispensing revenue stream for participating pharmacies through three key partnerships, with interest from additional potential partners. "In the trials that we have performed, we have far outperformed other avenues that drug trial sponsors have used in the past."

CPESN® Virginia is preparing to launch the network's first value-based payer program to provide services to Medicaid patients enrolled in an Elevance/CarelonRx plan. Lura Thompson, CPESN VA Managing Network Facilitator, shares details in this video.

CPESN® Minnesota pharmacies will support prescribed use of medications for identified members enrolled in one of UCare’s Medicare plans. Lindsay Christensen, CPESN Minnesota's Executive Director, describes how network will provide direct support and education to promote medication adherence for hypertension, cholesterol, and diabetes medication, and will address gaps in statin therapy for cardiovascular health.

Medicaid patients of 18 CPESN® Iowa pharmacies showed improved outcomes for their mental health, asthma, and chronic obstructive pulmonary disease (COPD) with fewer ED visits and hospital admissions. Elevance Health reported the outcomes last week, concluding that value-based partnerships with CPESN community pharmacies can be an effective strategy to improve quality and lower costs for plan members with the most complex needs. Lindsey Ludwig, CPESN Iowa Managing Network Facilitator shares the details.